Home » Topics » Regulatory » EMA

EMA
RSS

Aldara recommended for approval for actinic keratosis in Europe

Oct. 23, 2006

Positive opinion handed down in Europe for new Glivec indication

Oct. 23, 2006

Europe's CHMP recommends Hycamtin for new indication

Oct. 23, 2006

Tandemact recommended for approval in E.U.

Oct. 23, 2006

European CHMP issues positive opinion on Diacomit submission

Oct. 23, 2006

Adrovance recommended for approval in E.U.

Oct. 23, 2006

Novo Nordisk withdraws E.U. application to expand repaglinide product labels

Oct. 18, 2006

Withdrawal of E.U. marketing authorization for Fortovase

Aug. 14, 2006

Negative opinion handed down for Valdoxan/Thymanax in Europe

Aug. 3, 2006

Positive opinion handed down in Europe for Ganfort

March 28, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...